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Abstract
Background: Leptospirosis is caused by pathogenic spirochetes of the genus Leptospira. The bacteria enter the human body
via abraded skin or mucous membranes and may disseminate throughout. In general the clinical picture is mild but some
patients develop rapidly progressive, severe disease with a high case fatality rate. Not much is known about the innate
immune response to leptospires during haematogenous dissemination. Previous work showed that a human THP-1 cell line
recognized heat-killed leptospires and leptospiral LPS through TLR2 instead of TLR4. The LPS of virulent leptospires
displayed a lower potency to trigger TNF production by THP-1 cells compared to LPS of non-virulent leptospires.
Methodology/Principal Findings: We investigated the host response and killing of virulent and non-virulent Leptospira of
different serovars by human THP-1 cells, human PBMC’s and human whole blood. Virulence of each leptospiral strain was
tested in a well accepted standard guinea pig model. Virulent leptospires displayed complement resistance in human serum
and whole blood while in-vitro attenuated non-virulent leptospires were rapidly killed in a complement dependent manner.
In vitro stimulation of THP-1 and PBMC’s with heat-killed and living leptospires showed differential serovar and cell type
dependence of cytokine induction. However, at low, physiological, leptospiral dose, living virulent complement resistant
strains were consistently more potent in whole blood stimulations than the corresponding non-virulent complement
sensitive strains. At higher dose living virulent and non-virulent leptospires were equipotent in whole blood. Inhibition of
different TLRs indicated that both TLR2 and TLR4 as well as TLR5 play a role in the whole blood cytokine response to living
leptospires.
Conclusions/Significance: Thus, in a minimally altered system as human whole blood, highly virulent Leptospira are potent
inducers of the cytokine response.
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Introduction
Leptospirosis transmission occurs worldwide and comprises all
infections caused by pathogenic spirochetes of the genus Leptospira
[1]. Currently over 260 serovars are known, traditionally grouped
into several serogroups [2]. Being spread by the urine of infected
animals, the bacteria enter the human body via abraded skin,
conjunctivae or mucous membranes, after which they may
disseminate throughout the body. The majority of infections are
thought to result in a mild illness with rather non-specific
symptoms like fever, myalgia and headache. Some patients
develop severe disease, which is often rapidly progressive and
can be fatal in up to 70% of patients with severe pulmonary
disorders [3].
The clinical picture of severe leptospirosis is dominated by
hepato-renal impairment and hemorrhages. Patients usually die
from septic shock with multi-organ failure and/or overt
(pulmonary) hemorrhages. Pathological findings reveal wide-
spread haemorrhaging in virtually all organs and tissues with
diffuse inflammatory infiltrates [4]. Leptospira antigen has been
identified in many organs, including lungs, liver and kidneys
[4–6]. It is believed that leptospires migrate through intercellular
junctions, however electron microscopy demonstrated bacteria
within the cytoplasm, not contained in a membrane compart-
ment [7].
Immunity against Leptospira depends on the production of
circulating antibodies directed against serovar specific lipopoly-
saccharides (LPS). Interestingly, leptospiral LPS differs from gram-
negative LPS in several biochemical, physical and biological
properties [8]. Although crucial in the early stage infection,
not much is known about the innate immune response to
Leptospira. Several cytokines such as interferon (IFN)-c, interleukin
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(IL)-12p40 and TNF-a, are released during infection [9–12]. A
human monocytic cell line (THP-1), transfected with human
CD14 was able to recognize heat-killed leptospires and leptospiral
LPS through toll-like receptor (TLR)2 but not TLR4 [13] while
TLR4 is considered to be the predominant receptor mediating a
LPS induced cytokine response. Subsequent murine models,
using either heat-killed and live bacteria or LPS, showed evidence
that both TLR2 and TLR4 play a role [14,15]. Leptospiral LPS
was shown to be recognized by both TLR2 and TLR4 in murine
cells [14] whereas leptospiral lipoproteins were recognized by
TLR2 in murine kidney epithelial cells [16]. Mice with combined
TLR2/TLR4 deficiency were found to be highly susceptible to
lethal leptospirosis [15,17,18]. However, these previous studies
might not be representative of the immune response to viable
serovars in humans. Hence, in the present study we investigated
the innate immune response to several viable leptospiral serovars
in human blood. Killing assays and stimulation experiments were
performed using a human monocytic cell line (THP-1), human
peripheral blood mononuclear cells (PBMC) and human whole
blood. Moreover we examined the involvement of TLR2, TLR4
and TLR5 in the cellular responsiveness to viable Leptospira
serovars.
Methods
Ethics statement
All animal protocols were approved according to the Cruelty to
Animals Act, 1876, as amended by European Communities
(Amendment to cruelty to Animals Act 1879) Regulations 2002
and 2005. All animal protocols were reviewed by the University
College Dublin Animal Research Ethics committee, approval P-
42-05, and licensed by the Department of Health & Children,
Ireland, license number B100/3682. All animal protocols were
conducted according to Institution guidelines for animal hus-
bandry, and in accordance with the principals of Replacement,
Reduction and Refinement.
From the human blood donors written informed consent was
obtained and the protocol was reviewed by the Medical Ethics
Committee from the Academic Medical Center from the
University of Amsterdam. This committee concluded that the
Medical Research Involving Human Subjects Act does not apply
on the presented study and that therefore official approval of this
study by the Committee was not required.
Bacteria and reagents
Several leptospiral strains from the WHO/FAO/OIE and
National Collaborating Centre for Reference and Research on
Leptospirosis, Amsterdam, The Netherlands, were used. Patho-
genic reference strains: Leptospira interrogans serovar Bataviae strain
Swart and L.interrogans serovar Lai strain Lai. These strains have
been passaged for more than 20 years. For clarity reasons we refer
to these strains as ‘culture-adapted’ throughout this paper. Recent
isolates of L.interrogans serovar Bataviae and serovar Lai were
obtained from leptospirosis patients. L.interrogans serovar Bataviae
strain Kariadi-Satu was isolated in 2005 from an adult male
admitted at the Dr Kariadi Hospital in Semarang, Indonesia,
identified by cross-agglutinin absorption test (CAAT)[19] and
sequencing [20] for serovar and species determination. Strain
Kariadi-Satu was aliquoted and stored at –70uC shortly after
isolation, i.e. after four in vitro passages, to maintain the integrity as
human host-adapted variant of the reference strain. L.interrogans
serovar Lai type Langkawi strain Langkawi was isolated from a
Dutch hospitalized adult male tourist [21]. Strain Langkawi was
aliquoted and stored at 270uC one year after isolation
(approximately 15 in vitro passages). We refer to these two
leptospiral isolates with low to moderate passage numbers as
‘host-adapted’ in this paper.
Saprophytic (non-pathogenic) reference strain L.biflexa serovar
Patoc strain Patoc I and virulent L.interrogans serovar Copenhageni,
designated RJ16441 were from the collection of the Veterinary
Sciences Centre, University College Dublin, Ireland. Strain
RJ16441 was obtained from a patient suffering from a severe
pulmonary form of leptospirosis [22] and low in vitro passages of
this isolate were passed through guinea pigs to maintain virulence
[23].
Leptospires were grown in liquid Ellinghausen McCullough
Johnson and Harris medium (EMJH), in house prepared [24]. For
testing, 50 ml of a full grown culture was inoculated into 500 ml of
EMJH at 30uC in a shaking incubator for 5–7 days.
Prior to the experiments, leptospires were thoroughly washed 3
times with RPMI 1640 (Invitrogen, Paisley, Scotland, UK) to
remove possible LPS contamination from the culture medium,
counted using a Helber Counting Chamber (Hawksley, Lancing,
Sussex, UK) under darkfield microscopy and resuspended at a
concentration of 2.56109 bacteria/ml from which further 10-fold
dilutions were made in RPMI 1640. To heat-kill, washed
leptospires were subjected to a 30 min treatment at 56uC prior
to dilution in appropriate concentrations.
Virulence assay by infection of guinea pigs
The virulence of leptospiral strains was qualitatively checked
by i.p. injection of guinea pigs with each of the Leptospira strains
according to the standard guinea pig model [23]. For each strain
four guinea pigs were injected. Virulent strain RJ16441 was used
as a positive control and the saprophytic strain Patoc I was used
as negative control. For both positive and negative control one
guinea pig was injected. Hartley male guinea pigs (Charles River
Laboratories, UK) at 3 weeks of age, weighing 250 to 330 g were
injected intraperitoneally with 107 in vitro cultivated Leptospira in a
final volume of 500 ml medium. Animals were monitored daily
for signs of illness including weight loss and loss of mobility, and
were euthanized when they appeared moribund. If no illness
developed, they were euthanized on day 7 post infection.
Liver and kidneys were cultured to detect the presence of
leptospires.
Evaluation of LigA expression
LigA expression of the different Leptospira strains was detected by
Western blotting. Only fresh, virulent isolates are thought to
express this protein [25]. Rabbit anti-LigA raised against the
fragment called LigANI (amino acids 625–1224) and purified
truncated LigA as positive control were both generously supplied
by the Goncalo Moniz Research Centre, Fundacao Oswaldo Cruz
Foundation, Salvador, Brazil. Leptospires were cultured and
enumerated as described above, spun down at 1730 g for 30 min
and then washed twice with PBS+5 mM MgCl2 wash buffer to
form pellets containing 26108 leptospires/pellet. The pellets were
resuspended in SDS sample buffer containing b-mercaptoethanol
for standard SDS-PAGE under reducing conditions on 7.5%
polyacrylamide gels. Following electrophoresis, the separated
proteins were transferred to a nitrocellulose membrane and
membranes were blocked with 4% skimmed milk in PBS 0.05%
Tween 20. Subsequently membranes were probed with primary
rabbit anti-LigA antibody followed by detection of positive bands
using goat anti-rabbit immunoglobulin conjugated with horserad-
ish peroxidase (Jackson ImmunoResearch Laboratories. Inc) and
DAB staining.
Human Immune Response Against Leptospira in Blood
PLoS ONE | www.plosone.org 2 March 2011 | Volume 6 | Issue 3 | e18279
THP-1 monocytes
The THP-1 monocyte cell line was obtained from American
Type Culture Collection (ATCC: TIB 202). Cells were cultured in
RPMI 1640 containing 10% FCS (Invitrogen, Paisley, Scotland,
UK), 2 mM glutamin (Lonza, Basel, Switzerland), 40 U/ml
penicillin, 40 mg/ml streptomycin and 0.1 mg/ml amphotericin
B (Invitrogen, Paisley Scotland UK) and incubated at 37uC, 5%
CO2. Four days before the experiment, cells were washed with
RPMI 1640/10%FCS/2 mM glutamin medium without antibi-
otics and antimycotics and sub-cultured in this medium. Prior to
the experiment THP-1 cells were spun down and resuspended in
fresh RPMI 1640/10%FCS/2 mM glutamin to approximately
26106 cells/ml. For experiments with normal human serum
(NHS), filtrated, heat inactivated NHS (Sanquin, Amsterdam, the
Netherlands) was added to the medium at a final concentration of
2% (v/v).
Peripheral Blood Mononuclear Cells
Heparinized blood was collected aseptically from healthy
donors without a known history of leptospiral infection and
PBMC were obtained using LymphoprepTM (Axis-Shield, Oslo,
Norway) according to the manufacturer’s guidelines. Briefly, blood
was diluted 1:1 with pyrogen free 0.9% NaCl and carefully layered
on top of the Lymphoprep solution and centrifuged 20 min at
800 g. The distinct band of Peripheral Blood Mononuclear Cells
(PBMC) was harvested, washed with RPMI 1640 and resuspended
in this medium to the same volume of the original blood.
Whole Blood
Shortly before starting the experiment, heparinized blood was
collected aseptically from healthy donors without a known history
of leptospiral infection.
Statistic methods
All experiments were performed in quadruplicate and repeated
at least once. Data are presented as mean values with standard
deviations. As all data was normally distributed, Students t-test was
used to test for significance, whereas the a was set on 0.05. In case
of experiments using whole blood or derivates, blood of two
distinct donors was used.
Innate immune response experiments
Fifty ml of whole blood or cell suspensions prepared as described
above were put in the wells of a 96 well tissue culture plate
(Greiner Bio-One GmbH, Frickenhausen, Germany, CELLSTAR
96-Well Polystyrene). Leptospires were diluted in RPMI 1640 until
appropriate concentrations were reached. Final concentrations
ranged from 2.56104 to 2.56108 bacteria/ml. Leptospires were
added to the various cell suspensions to a final volume of 100 ml
per well. As a blank, RPMI 1640 was used in all experiments.
Concentrations of PBMC were equivalent to 50 ml whole blood
per well (approximately 0.56106/ml monocytes). Plates were
incubated for six hours at 37uC, 5% CO2. After incubation plates
were centrifuged and supernatant was collected and stored at
270uC until further testing. To study TLR engagement, specific
cell culture grade inhibitory monoclonal antibodies to human
TLR2, TLR4 and TLR5 (InvivoGen, Toulouse, France, anti-
hTLR2-IgA, anti-hTLR4-IgA and anti-hTLR5-IgA) were used.
Control experiments were done using FSL-1 1 mg/ml,
Pam3CSK4 100 ng/ml, LPS 1 ng/ml (E.coli ultrapure) and
Flagellin 1 mg/ml (purified flagellin from S.typhimurium) from
InvivoGen, known for their capacity to signal through TLR2,
TLR2, TLR4 and TLR5 respectively. Antibodies were diluted in
RPMI 1640 and added into the assay at a final optimal
concentration of 2500 ng/ml, 1000 ng/ml and 1000 ng/ml
respectively. Antibodies were preincubated in whole blood for
30 min prior to incubation with leptospires. Leptospires were
added at a final concentration of 2.56105 leptospires/ml to mimic
the physiological situation found in severe patients, where
leptospires concentrations usually range between 104–105 lepto-
spires/ml, occasionally higher [26,27].
Cytokines assays. Levels of TNF-a in culture supernatants
were determined by enzyme-linked immunosorbent assay
(Biosource Europe SA Nivelles Belgium, human TNF-a
CytoSetsTM) according to the instructions of the manufacturer.
IL-6 was determined using a cytometric beads array multiplex
assay (BD Biosciences, San Jose, CA) according to the instructions
of the manufacturer.
Killing assay. To evaluate the sensitivity of the different
Leptospira strains to killing by host factors or cells, we incubated
2.56106 Leptospira/ml with whole blood, PBMC, THP-1 and 2%
NHS from a healthy donor (without a known history of leptospiral
infection, not heat inactivated) for six hours at 37uC, 5% CO2.
Concentrations and final volumes were identical to the incubation
experiments described above. Of every sample 50 ml was
transferred into 450 ml EMJH supplemented with 0.02% 5-
fluorouracil to avoid contamination. Numbers of viable bacteria
were estimated by limiting dilution using serial ten-fold dilutions of
samples. Growth was checked after 3 weeks incubation at 30uC by
dark field microscopy.
Results
Virulence testing of L. interrogans strains by infection of
guinea pigs
The virulence of the L. interrogans strains used herein of serovars
Bataviae and Lai was evaluated in the standard guinea pig model
by i.p. injection of viable bacteria. The culture-adapted serovar
Bataviae and Lai strains had completely lost their virulent
phenotype as displayed by failure to induce weight loss or
pathology and by complete clearance of viable bacteria of these
strains in the guinea pig infection model (Figure 1). The host-
adapted isolates are virulent based on stagnation of weight,
infection and pathology (Figure 1).
Virulence testing by detection of LigA
Western blot analysis showed that the host-adapted virulent
L.interrogans serovar Bataviae clearly expressed LigA. The protein
was only weakly detectable in the host-adapted serovar Lai,
which was subjected to about ten more in vitro passages than
Bataviae and was absent in culture-adapted and non-pathogenic
strains (Figure S1).
Different innate immune response to heat-killed and
alive L. interrogans
Former studies investigating the innate immune response
elicited by L. interrogans were focused on the heat-stable
lipopolysaccharide moiety of these bacteria. However, since host
cells encounter living bacteria during infection we compared the
response of human monocytic cells (THP-1 cell line) to heat-killed
and viable preparations of the culture-adapted and host-adapted
strains from serovars Bataviae and Lai mentioned above. In
Figure 2 the THP-1 response to the heat-killed leptospires is
shown. Consistent with the previous study of Werts and co-
workers [13], the heat-killed host-adapted serovar Bataviae isolate
displayed a much lower potency to stimulate THP-1 cells
compared to the corresponding heat-killed culture-adapted
Human Immune Response Against Leptospira in Blood
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Bataviae serovar. Thus our data with serovar Bataviae are fully
consistent with the notion that host-adapted virulent heat-killed
L. interrogans are less potent innate immune activators than heat-
killed culture-adapted avirulent L.interrogans. However, in contrast
the heat-killed host-adapted serovar Lai and corresponding heat-
killed culture-adapted serovar Lai displayed both the same potency
as the culture-adapted serovar Bataviae. Interestingly, incubations
of living preparations of the host-adapted serovar Lai and the
culture-adapted serovars Lai and Bataviae resulted in a similar
response of the THP-1 cells when compared to the heat-killed
response with these bacteria. However, the viable preparation
of the host-adapted Bataviae isolate displayed a remarkable
Figure 1. Virulence testing in guinea pigs. Hartley male guinea pigs (3 weeks of age) were injected intraperitoneally with 107 in vitro cultivated
leptospires. All guinea pigs were between 250–330 g on the day of infection (day 0). Panel A. Record of guinea pig weights. Weight is represented as
percentage of average weight on day 0. Weights were recorded daily until euthanasia. Panel B. Lung gross pathology following infection with
leptospires. (Bi) Typical example of culture-adapted serovar Bataviae and Lai, in guinea pig failing to induce pathology, (Bii) Typical example of host-
adapted serovar Bataviae and Lai in moribund guinea pigs, showing diffuse pulmonary hemorrhages. Panel C. Culture results of kidney and liver
tissue and pathology from guinea pigs post mortem. Pathology is considered consistent with acute leptospirosis when progressive weight loss,
profound pathology, jaundice and pulmonary haemorrhage are observed.
doi:10.1371/journal.pone.0018279.g001
Human Immune Response Against Leptospira in Blood
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significantly enhanced potency to stimulate THP-1 cells. It can be
concluded that the virulent Bataviae strain lost a large part of its
potency to activate an innate immune response upon heat-killing,
and that living virulent leptospires may exert a relative potent
stimulating effect on human monocytes. Since the THP-1 cell line
is not exclusively an appropriate model for human monocytes we
performed stimulations with human PBMC. The response to
living leptospires by PBMC was more vigorous to both culture-
adapted strains when compared to the host-adapted strains
(Figure 3). Interestingly, in this PBMC employing test the
culture-adapted Bataviae strain was most potent, while this strain
displayed equal potency in THP-1 triggering as both host-adapted
and culture-adapted Lai strains tested either heat-killed or alive.
Similar observations were obtained with PBMC from 2 different
donors. The above indicates that the relative potency to trigger
innate immune responses of genetically indistinguishable virulent
and avirulent leptospiral strains, as determined by secY sequence-
based phylogeny (not shown) is largely dependent on the way of
application (alive or heat-killed) and the cell type used.
Whole blood
During the pathophysiology of leptospirosis leptospires are spread
through the blood stream. To explore the proinflammatory potency
of this compartment in response to virulent and avirulent leptospires
we incubated the different leptospiral strains in a minimally altered
whole blood assay. Similar observations were obtained in two
different blood donors. Both culture-adapted strains were less potent
at inducing TNF-a at low bacterial burden compared to the virulent
host-adapted counterparts (Figure 4). At high, non-physiological,
concentrations all strains displayed the same potency in whole
blood. Similar dose-dependent responses were observed for IL-6
release (data not shown). In efforts to characterize the response in
whole blood we inhibited TLR2, TLR4 and TLR5 in physiolog-
ically relevant concentrations of the virulent host-adapted serovar
Bataviae [26,27]. This involvement of different TLRs was studied
using cell culture grade inhibitory antibodies from InvivoGen
shown to block either human TLR2, TLR4 or TLR5 and
developed for this purpose by the manufacturer. We confirmed
the inhibitory capacity of the antibody preparations in control
experiments (Figure S2). The majority of TNF-a production
induced by virulent leptospires in whole blood could be inhibited
with either anti-TLR2 or anti-TLR4 (Figure 5B). Remarkably,
combined inhibition of both TLR2 and TLR4 did not further
reduce the response driven by the host-adapted leptospires
(Figure 5B). Blocking of TLR5 also significantly reduced TNF-a
production by this host-adapted strain. Combined TLR2/TLR4/
TLR5 inhibition did not result in further decrease of TNF-a release
than when blocking the distinct TLRs. Blockade of TLRs showed a
somewhat different pattern of inhibition on IL-6 release where anti-
TLR2 was only moderately effective in decreasing IL-6 production.
Combined blocking of TLR2 and TLR4 was most effective in
inhibition of IL-6 release by this host-adapted serovar Bataviae
(Figure 5C). When whole blood was incubated with the corre-
sponding culture-adapted strain, the stimulation of TNF-a release
by the same dose of leptospires was much lower (Figure 5A)
compared to the host-adapted strain as was shown in our previous
experiments. The minor amount of TNF-a induced by this non-
virulent strain was slightly inhibited by blockade of either TLR2,
TLR4 or TLR5, and completely prevented by combined inhibition
of TLR2, TLR4 and TLR5.
Killing of the different Leptospira strains by host factors
In whole blood the host-adapted leptospires seemed more
potent in initiating an immune response than the culture-adapted
leptospires, at least at moderate bacterial load, whereas isolated
PBMC were more responsive to culture-adapted leptospires.
Figure 2. Activation of THP-1 cells with heat-killed and live leptospires. Cells were stimulated for 6 h with varying concentrations of
leptospires. TNF-a concentrations were measured from cell culture supernatants. Data represent the mean values of quadruplicate experiments. Error
bars represent the standard deviation (SD) of the mean. Panel A: Heat killed leptospires; panel B: Alive leptospires. The response of all blanks was
below the baseline and therefore is not shown.
doi:10.1371/journal.pone.0018279.g002
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Apparently, the way of exposure of leptospires to cytokine
producing cells is different in whole blood compared to the
exposure of leptospires in a purified mononuclear cell fraction of
blood. This prompted us to test potential killing of the leptospiral
strains by the different cell types, complement, or whole blood.
The viability of the different leptospiral strains was evaluated semi-
quantitatively by culture of serial dilutions of leptospires incubated
with the different cells or blood components.
As shown in Figure 6 incubations with THP1 cells or PBMC did
not affect the viability of any of the used leptospiral strains. Upon
incubation with serum and whole blood the culture-adapted
strains were killed, while the host-adapted strains displayed
complete serum resistance and also survived the 6 hour whole
blood incubation. Incubation with heat-inactivated serum did not
result in killing of the culture-adapted strains (data not shown)
which is in agreement with complement mediated killing of
avirulent leptospires by normal serum. Consistent with the
presence of host-adapted virulent leptospires in the organs of
infected guinea pigs, these observations indicated that the culture-
adapted leptospiral strains are efficiently and rapidly destroyed by
complement activity while the host-adapted leptospiral counter-
parts evade complement dependent killing and also do not loose
their integrity in whole blood. Obviously, the most important
difference in stimulating cytokine release between host-adapted
and culture-adapted strains is that the latter will be killed promptly
when entering the blood and thus remain below physiological
concentrations needed for detectable stimulation.
Discussion
Leptospirosis can cause severe human disease, leading to
bleeding, multi-organ failure and septic shock. The disease is
caused by strains of the Leptospira bacteria that may differ in their
LPS moiety which is used to discriminate the different leptospiral
serovars [3]. Previous reports identified TLR2 as the innate
receptor that recognizes Leptospira derived LPS as well as heat-
Figure 3. Activation of PMBC with live leptospires. Cells were stimulated for 6 h with varying concentrations of leptospires. TNF-a
concentrations were measured from cell culture supernatants. Data represent the mean values and error bars represent the standard deviation (SD)
of the mean. The response of all blanks was below the baseline and therefore is not shown.
doi:10.1371/journal.pone.0018279.g003
Figure 4. Activation of whole blood with live leptospires.Whole blood was stimulated for 6 h with varying concentrations of leptospires. TNF-
a concentrations were measured from cell culture supernatants. Data represent the mean values and error bars represent the standard deviation (SD)
of the mean. The response of all blanks was below the baseline and therefore is not shown.
doi:10.1371/journal.pone.0018279.g004
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killed whole Leptospira bacteria [13,14]. Furthermore, the LPS
from virulent leptospires was found to be a weaker activator of
monocytes than the LPS from avirulent leptospires [13]. These
findings suggested that TLR4 is not involved in the host response to
leptospiral LPS, and that a potential escape mechanism of virulent
bacteria occurs by concealment of the TLR2 activating LPS
structure. In order to further elucidate how the innate immune
system reacts to Leptospira we confirmed the observations with heat-
killed bacteria by Werts and co-workers [13] using a monocytic cell
line and comparing two culture-adapted strains representing
attenuated non-virulent leptospires with their host-adapted, virulent
counterparts. Indeed, when using heat-killed bacteria, the host-
adapted L. interrogans serovar Bataviae was weakest in stimulating
THP-1 cells consistent with the earlier report. However, when this
host-adapted leptospiral strain was incubated alive on the
monocytic cells it showed an importantly higher potency to activate
immune cells in comparison to the culture-adapted strain. These
experiments indicated that the host-adapted serovar Bataviae
displays an important, as yet to be identified, immune activation
pathway that is lost upon heat inactivation of the bacteria. However,
this phenomenon did not occur when executing the experiment
with the serovar Lai counterparts. This serovar displayed similar
responses irrespective of its killed or viable status and for both host-
adapted and culture-adapted strains. There are two possible
explanations for this observation.
Firstly, differences in responses might reflect differences in
expression of potential virulence factors in the two serovars. The
host-adapted serovar Lai showed a markedly lower expression of
LigA compared to the host-adapted serovar Bataviae, which is
consistent with its higher number of in vitro passages [25].
Differential expression might very well have occurred for other
bacterial cell components [28,29]. In the guinea pig model, both
the host-adapted serovar Lai and Bataviae escaped complement
killing in the blood, enabling Lai to adapt, grow and disseminate,
thus regaining its full host-adapted constitution. However,
incubation time and conditions with THP-1 cells most probably
did not enable such adaptation and results therefore might reflect a
host interaction with a pathogen sharing more features similar to a
culture-adapted than to a host-adapted form. This option is
important as it suggests that virulence testing of Leptospira strains in
animals alone may not be a reliable marker for their in vitro
performance. Secondly, it cannot be excluded at this stage that
serovar specificity does account for the differences in cytokine
responses by THP-1 cells. In this respect it should be noted that,
whereas no specific clinical manifestations can be associated with
distinct serovars, some serovars tend to cause more serious disease
than others [30]. Both explanations for different in vitro behaviour
of the two host-adapted strains are highly relevant as these will
have consequences for future interpretations of in vitro experiments
on innate immune responses. Therefore, it is important to further
investigate the role of differential gene expression and serovar
specificity in innate immune responses. Differences in the outcome
of in vitro experiments apparently is also associated with the type of
host cells used in the tests because different TNF-a release profiles
were observed when using PBMC compared to THP-1 cells. This
observation prompted us to determine the host reaction to
different leptospiral isolates in a relevant minimally altered
physiological system. For this purpose we conducted whole blood
incubations with viable leptospires in which we were able to show
that host-adapted leptospires are as potent activators of the innate
immune system as culture-adapted leptospires. Furthermore, at
physiologically relevant bacterial burden host-adapted leptospiral
strains of different serovars (Lai and Bataviae) displayed both an
enhanced potency to stimulate the innate immune system
compared to the respective culture-adapted strains. The main
difference between the host-adapted isolates and their culture-
adapted counterparts was the complete resistance of the host-
adapted isolates to killing by whole blood and serum while the
Figure 5. TLR2, TLR4 and TLR5 mediate activation of whole
blood in response to live leptospires. Whole blood was stimulated
with 2.56105/ml leptospires of host- and culture-adapted serovar
Bataviae in the presence of anti-TLR2, anti-TLR4 and anti-TLR5
antibodies. Data represent mean TNF-a and Il-6 values. Error bars
represent the standard deviation (SD) of the mean. Asterisks represent
the significance: p value,0.001 ***, 0.001–0.01 **, 0.01-0.05 * compared
to the control. Panel A: TNF-a response of culture-adapted serovar
Bataviae. Panel B: TNF-a response of host-adapted serovar Bataviae.
Panel C: IL-6 response of host-adapted serovar Bataviae
doi:10.1371/journal.pone.0018279.g005
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culture-adapted strains were rapidly killed. It should therefore be
noted that differences found in stimulation and inhibition
experiments only are of ‘academic’ interest i.e. infection with
attenuated culture-adapted leptospiral strains will at the best result
in the transient presence of low numbers in the blood, incapable of
eliciting detectable responses. Hence further discussion focuses on
results obtained with host-adapted strains. Host-adapted L.
interrogans serovar Bataviae induced TNF-a and IL-6 release in
whole blood that was partially TLR2 and TLR4 as well as TLR5
dependent. Single blockade of either TLR2, TLR4 or TLR5
prevented a large part of the TNF-a production induced by the
host-adapted leptospires while combined inhibition of TLR2/4/5
did not result in a further reduction of this innate immune
response. One possible explanation might be that cytokine release
was stimulated in a manner that is suggestive for synergistic
cooperation of TLR2, TLR4 and TLR5. We hypothesized that
viable virulent leptospires may trigger the host response in whole
blood by more concentrated pathogen-associated molecular
patterns (PAMP’s) exposed on their intact surface. Since induction
of signaling by human TLR4 through LPS of L. interrogans is
unlikely [13,14] the observed TLR4 involvement may be caused
by TLR4 activating released danger-associated molecular patterns
(DAMP’s) such as HmgB1 and MRP-8 [31] by host cells upon
encounter of living specimen of this invasive genus of bacteria
[32]. It has been suggested that TLR5 may cooperate with TLR4
in response to flagellin [33], also in whole blood [34], so another
possibility is that TLR4 is engaged in a TLR5 dependent response
in whole blood to living virulent L. interrogans (Figure 5). However,
Figure 6. Killing of leptospires. Abbreviations: sv, serovar; NHS, normal human serum. Leptospires are incubated for 6 hours. 10-fold serial
dilutions were made after 6 h in EMJH, and leptospiral growth was evaluated after 3 weeks incubation at 30uC. Culture- and host-adapted serovar
Bataviae, culture- and host-adapted serovar Lai were used under the following conditions: Panel A: THP-1 cells, panel B: PBMC, panel C: whole blood,
panel D: NHS
doi:10.1371/journal.pone.0018279.g006
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leptospiral flagella are located in the periplasm [35]. In case of
virulent leptospires that are capable to survive in the blood,
flagellin mediated triggering through TLR5 is not likely to occur.
We argue that not all virulent leptospires may evade complement
killing and that part of them are lysed resulting in exposure of
flagellins in sufficient amounts to stimulate TLR5 response. It
should be noted that only very low amounts of flagellin are needed
to achieve a TLR5 mediated response [36]. Further research will
be needed to confirm or refute this hypothesis. It must be noted
that IL-6 production also indicated a role for TLR2, TLR4 and
TLR5, however IL-6 production was more markedly reduced by
combined inhibition of TLRs. This difference in TLR dependence
between TNF-a and IL-6 production may be due to the
differences in the pathways regulating gene expression and
translation of these mediators (reviewed in [31]). In our
experiments we observed similar cytokine responses in two donors.
However, donor dependent differences in TLR2 and TLR4
pathways have been reported in a significant proportion of global
populations [37]. Therefore, we can not exclude host dependent
factors in cytokine responses at this stage.
To the best of our knowledge, we are the first to show that
TLR2 as well as TLR4 and TLR5 play a role in the response to
viable pathogenic leptospires in a human whole blood model.
Basically, human whole blood incubations with viable lepto-
spires revealed that virulence characteristics of L. interrogans are
associated with complete resistance to killing by normal whole
blood, and not with impaired recognition by the cellular receptors
of the innate immune system. These results are in line with
previous work showing that pathogenic leptospires are able to
survive in the non-immune host by evading, to various degree,
complement-mediated killing [5,38]. Although C3 is probably
equally deposited on both non-pathogenic and pathogenic strains,
the latter are able to bind factor H on their surface which is a
strong inhibitor of the complement (C) system [5,39]. In another
study, Anderson and Johnson [40] showed by electron microscopy
that leptospires belonging to saprophytic strain Patoc I and non-
virulent serovar Canicola retained their shape but lost their outer
sheath after incubation with complement and immune serum. In
contrast, leptospires of the virulent serovar Canicola were not
affected at all by complement and antibodies.
Incubation with either THP-1 cells or PBMC did not result in
killing of any of the viable leptospiral strains. Indeed, previous
studies reported similar findings [41,42], suggesting that phago-
cytosis or the release of bactericidal mediators are not major
processes involved in the killing of leptospires. An important
conclusion on this observation is that caution is needed by
interpretation of results obtained with stripped models for
exploring cytokine responses upon leptospiral infection. Addition-
ally, the data presented herein emphasize the importance to use
viable low passage isolates to study the host response to Leptospira
infection.
In conclusion, our results show that the innate human host
response to leptospiraemia involve, but may not be limited to the
action of TLR2, TLR4 and TLR5. Further research is needed on
the mechanism of interactions of these TLRs to unravel their
involvement during human leptospirosis.
Supporting Information
Figure S1 LigA westernblot. Westernblot of whole lysates of
leptospires detected with rabbit anti-LigA antibody as follows: lane 1
contains host-adapted serovar Lai type Langkawi, lane 2 host-
adapted serovar Bataviae, lane 3 reference serovar Patoc strain Patoc
I. Size markers are indicated to the left. The faint band of serovar Lai
type Langkawi has largely been lost by the reproductions.
(TIF)
Figure S2 Controls. Human whole blood stimulation with
different ligands in the absence or presence of TLR-inhibiting
antibodies. Concentration of the ligands are as indicated. Anti-
TLR antibodies were added at the following concentrations:
2500 ng/ml anti-TLR2, 1000 ng/ml anti-TLR4 and anti-TLR5.
Polymixin B (PMB), 10 mg/ml, was added to compensate effects
by residual free LPS in the various ligands. Significant cross-
inhibition of blocking antibodies to heterologous TLRs did not
occur (not shown).
(TIF)
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